Genomic and biological study of fusion genes as resistance mechanisms to egfr inhibitors

HIGHLIGHTS

• who: Yoshihisa Kobayashi from the Cell lines and drugs The , NSCLC cell line harboring EGFR mutant (del, _A750) was originally established in Tokyo Medical University and obtained from DrNishio Kazuto (Kindai University, Osaka, Japan) in, and confirmed by fingerprinting. , cells were grown in , (Gibco), % FBS, and, % penicillin/streptomycin (Gibco). Throughout the study, cells were periodically tested for Mycoplasma, using the Mycoplasma Plus PCR Primer Set (Agilent). All drugs used are listed in Supplementary Data, . have published the Article: Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors, in the Journal: (JOURNAL) of 30 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.